Background: Hepatocellular carcinoma (HCC) is a significant health problem, and the associated mortality rate is increasing.
Aim: We aimed to determine the clinical characteristics and prognosis for HCC in member countries of the OncoBridge Study Group.
Methods: We recruited 630 patients diagnosed with HCC between 2013 and 2019 from 4 countries (Türkiye, Russia, Georgia, and Greece).